Cargando…

Market menagerie : health and development in late industrial states /

Srinivas examines technological advance and market regulation in the health industries of nations such as India, Brazil, South Africa, Nigeria, and China. Pharmaceutical and life science industries can reinforce economic development and industry growth, but not necessarily positive health outcomes....

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Srinivas, Smita (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Stanford, California : Stanford Economics and Finance, an imprint of Stanford University Press, 2012.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Mi 4500
001 JSTOR_ocn794770199
003 OCoLC
005 20231005004200.0
006 m o d
007 cr |n|||||||||
008 120515s2012 caua ob 001 0 eng d
040 |a NhCcYBP  |b eng  |e pn  |c UBY  |d E7B  |d OCLCO  |d YDXCP  |d OCLCQ  |d N$T  |d OTZ  |d OCLCQ  |d OCLCF  |d OCLCO  |d OCLCQ  |d AZK  |d LOA  |d AGLDB  |d OCLCQ  |d JBG  |d OCLCQ  |d PIFAG  |d OCLCQ  |d ESU  |d OCLCQ  |d WRM  |d NRAMU  |d OCLCA  |d INT  |d WYU  |d OCLCQ  |d STF  |d OCLCQ  |d JSTOR  |d QGQ  |d K6U  |d OCLCO  |d OCLCQ  |d SFB  |d OCLCQ 
019 |a 961518600  |a 962635498 
020 |a 0804781915  |q (electronic bk.) 
020 |a 9780804781916  |q (electronic bk.) 
020 |z 9780804780544  |q (alk. paper) 
020 |z 0804780544  |q (alk. paper) 
029 1 |a DEBBG  |b BV040869515 
029 1 |a DEBBG  |b BV042968106 
029 1 |a DEBSZ  |b 423717375 
029 1 |a DKDLA  |b 820120-katalog:000611216 
029 1 |a NZ1  |b 15024663 
029 1 |a AU@  |b 000055497023 
035 |a (OCoLC)794770199  |z (OCoLC)961518600  |z (OCoLC)962635498 
037 |a 22573/ctvqrrv7h  |b JSTOR 
043 |a a-ii---  |a d------ 
050 4 |a HD9672.I42  |b S67 2012 
072 7 |a BUS  |x 070000  |2 bisacsh 
072 7 |a BUS  |x 068000  |2 bisacsh 
082 0 4 |a 338.4/761510954  |2 23 
049 |a UAMI 
100 1 |a Srinivas, Smita,  |e author. 
245 1 0 |a Market menagerie :  |b health and development in late industrial states /  |c Smita Srinivas. 
260 |a Stanford, California :  |b Stanford Economics and Finance, an imprint of Stanford University Press,  |c 2012. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
588 0 |a Print version record. 
504 |a Includes bibliographical references and index. 
520 8 |a Srinivas examines technological advance and market regulation in the health industries of nations such as India, Brazil, South Africa, Nigeria, and China. Pharmaceutical and life science industries can reinforce economic development and industry growth, but not necessarily positive health outcomes. Yet well-crafted industrial and health policies can strengthen each other and reconcile economic and social goals. This book advocates moving beyond traditional market failure to bring together three uncommonly paired themes: the growth of industrial capabilities, the politics of health access, and the geography of production and redistribution. 
505 0 0 |g Machine generated contents note:  |g pt. I  |t Market Menagerie: Planning the Health of Late Industrial Development --  |t Introduction --  |t Health and Development in Late Industrial States --  |t Barbarians at the Gate: Late Industrial Supply --  |t Data, Methods, and Structure --  |t Chapters Ahead --  |t Appendix: Sample Questions --  |g 1.  |t Well Beyond Market Failure --  |t Time for Integration: Evolution of States and Markets --  |t Technology's Insights for Markets --  |t Extant Systems and the Weakness of Ideology for Reform --  |t Beyond Minimalism --  |t Bringing an Evolutionary Perspective to Development --  |t Fine Touch --  |g pt. II  |t 1950 -- 2000: Indian Market Menagerie --  |g 2.  |t First Market Environment: Trouble in the Making --  |t Phase I, 1950 -- 1970s: Coveted Universalism, Controlled Markets --  |t Crucible for Learning: The Public-Sector Effort --  |t Nehruvian Efforts in the Manufacture of Medicines --  |t Public-Sector Legacy Today --  |g 3.  |t "Essential" Markets, Public Health, and Private Learning --  |t 1970s and 1980s --  |t Process Patents --  |t Price Controls --  |t Monopolies, MNCs, and Accelerated Indian Learning --  |t Trouble in the Making: The New Drug Policy and Production --  |t Taking Stock --  |g 4.  |t Demand and Democracy --  |t Institutional Unraveling of Industrial Planning --  |t Planning for the Nation's Heartland and Outposts --  |t Demand and the Health of Health-Care Financing --  |t Industrial Slowdown and Fiscal Inertia --  |t Universalism and Demand Identities: From Control to Dissipation --  |t Reemergence of Nonmarket Institutions --  |t Ragged Edges of Consumption and Delivery --  |g 5.  |t Second Market Environment: Learning by Proving in Global Regulatory Harmonization --  |t National Universalism and Global Nationalism: The State's Loosening Hold on the Domestic Market --  |t Institutional Shifts to Global Nationalism --  |t Expansionist Market Tiers --  |t Growing Innovation, but Not Access? --  |t Looking Ahead --  |g 6.  |t Demand as Necessary but Not Sufficient: Vaccine Procurement Markets --  |t Vaccines --  |t Health for Some: The Development Mandate --  |t International Procurement Markets: Beyond Government Failure --  |t Procurement's Effect --  |t Fine-Tuning Demand Policy Instruments --  |t Learning by Proving: Health Policy as Industrial Policy --  |g 7.  |t Third Market Environment: Uncertain State of New Technologies --  |t Bringing the State Back into the Process --  |t Process, Process: New Technologies Ahoy! --  |t Advances Nevertheless --  |t New Technology Maps and Blurred Market Signposts: Organizational Vignettes --  |t Finally, Niches and Local Relevance --  |t New Interactions for Old Players --  |g pt. III  |t Institutional Basis for Industry and Health --  |g 8.  |t Health Technologies in Comparative Global Perspective --  |t Instituting Welfare Regimes: Building the Double Movement --  |t Pharmaceutical's Historical Advance: Early Capabilities, Early Welfare --  |t Private Property Markets --  |t Collective Rights and Markets in Welfare Institutions --  |t Varieties of Health-Care States --  |t Late Industrial Suppliers: Marrying Late Capabilities with Later Welfare --  |t Revisiting the Institutional Triad --  |t Moving Forward: Transitioning Developmental States --  |g 9.  |t Markets and Metropolis --  |t Design of (Re)distribution --  |t Nation and City in Development --  |t Universalism in Federalism: Between Capitalism and Commune --  |t Industrial Welfare and the City in Context --  |t Cities, Antibiotics, and Universalism --  |t From Poor Law to Welfare Paternalism in England and India --  |t Ahmedabad, circa 1915 --  |t Body Corporal and Politic: Utopias in Universalism --  |t Quest for Healthy Places --  |t Nations and Cities: An Evolving Social Contract? --  |t Limited Double Movement: Contractualism and Bo(u)nds of Exchange --  |t Conclusion: Soft Determinism in the Market Menagerie --  |t Infusing Evolution into Economic Plans --  |t Planning Process and Outcomes --  |t Soft Determinism in a New Pharmaceutical World --  |t Intervening in Variety --  |t Evolution and Orchestration of the Social Contract --  |t Market Variety and Morality: Planning with Small and Large "P." 
590 |a JSTOR  |b Books at JSTOR Demand Driven Acquisitions (DDA) 
590 |a JSTOR  |b Books at JSTOR All Purchased 
650 0 |a Pharmaceutical industry  |x Government policy  |z India. 
650 0 |a Pharmaceutical industry  |x Technological innovations  |z India. 
650 0 |a Health services accessibility  |z India. 
650 0 |a Medical policy  |z India. 
650 0 |a Pharmaceutical industry  |x Government policy  |z Developing countries. 
650 0 |a Pharmaceutical industry  |x Technological innovations  |z Developing countries. 
650 0 |a Health services accessibility  |z Developing countries. 
650 0 |a Medical policy  |z Developing countries. 
650 6 |a Industrie pharmaceutique  |x Politique gouvernementale  |z Inde. 
650 6 |a Services de santé  |x Accessibilité  |z Inde. 
650 6 |a Politique sanitaire  |z Inde. 
650 7 |a BUSINESS & ECONOMICS  |x Industries  |x General.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS / Development / Economic Development  |2 bisacsh 
650 7 |a Health services accessibility.  |2 fast  |0 (OCoLC)fst00953278 
650 7 |a Medical policy.  |2 fast  |0 (OCoLC)fst01014505 
650 7 |a Pharmaceutical industry  |x Government policy.  |2 fast  |0 (OCoLC)fst01060149 
650 7 |a Pharmaceutical industry  |x Technological innovations.  |2 fast  |0 (OCoLC)fst01060184 
651 7 |a Developing countries.  |2 fast  |0 (OCoLC)fst01242969 
651 7 |a India.  |2 fast  |0 (OCoLC)fst01210276 
776 0 8 |i Print version:  |z 9780804780544  |z 0804780544  |w (DLC) 2011043735 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.2307/j.ctvqsdn34  |z Texto completo 
938 |a ebrary  |b EBRY  |n ebr10594408 
938 |a EBSCOhost  |b EBSC  |n 713441 
938 |a YBP Library Services  |b YANK  |n 7436987 
994 |a 92  |b IZTAP